Patrick Verheyen - 11 Apr 2023 Form 3 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Director
Signature
/s/ Patrick Verheyen by Colin Sandercock
Issuer symbol
CUE
Transactions as of
11 Apr 2023
Net transactions value
$0
Form type
3
Filing time
13 Apr 2023, 16:43:24 UTC
Next filing
04 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CUE Common Stock 8,174 11 Apr 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 - Power of Attorney